Curcumin: A pleiotropic phytonutrient in diabetic complications
- Received 15 April 2014, Accepted 25 June 2014, Available online 18 July 2014
- Curcumin has shown pharmacologic effects in various diseases including diabetic complications.
- Curcumin's antioxidant and anti-inflammatory properties contribute majorly toward its protective effects.
- If supplemented with existing treatment modalities, curcumin can enhance efficacies and tone down associated side effects.
Curcumin is the major polyphenolic constituent of an indigenous herb, Curcuma longa, found to have a wide range of applications right from its kitchen use as a spicy ingredient to therapeutic and medicinal applications in various diseases. Curcumin has been identified to have a plethora of biologic and pharmacologic properties owing to its antioxidant and anti-inflammatory activities. This pleiotropic regulation of redox balance of cell and inflammation might be the basis of curcumin's beneficial activities in various pathologic conditions including diabetic complications. This review summarizes various in vitro, in vivo studies done on curcumin and its therapeutic utility in diabetic micro-vascular complications. This review also emphasizes the importance of curcumin in addition to the existing therapeutic modalities in diabetic complications.
- Diabetic complications;
- The authors declare no conflict of interest.
- Corresponding author. Tel.: +1 402 307 3741; fax: +1 402 307 3751.